The relationship between obesity and coronary artery disease (Q38204071)

31 August 2017

The relationship between obesity and coronary artery disease (English)

1 reference

31 August 2017

0 references

3

Carl J Lavie

1 reference

31 August 2017

Eiman Jahangir

1

1 reference

PubMed ID

24726461

31 August 2017

Alban De Schutter

series ordinal

2

1 reference

31 August 2017

22 March 2014

1 reference

31 August 2017

Translational Research

1 reference

31 August 2017

164

1 reference

31 August 2017

4

1 reference

31 August 2017

336-344

1 reference

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Impact of obesity on the pathogenesis and prognosis of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Are there persons who are obese, but metabolically healthy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Metabolic and body composition factors in subgroups of obesity: what do we know?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Can we identify metabolically healthy but obese individuals (MHO)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The metabolically healthy but obese individual presents a favorable inflammation profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

A prospective study of body mass index and the risk of developing hypertension in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease-the obesity paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Mechanisms linking obesity to hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Diabetes trends in the U.S.: 1990-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Metabolic syndrome and coronary heart disease equivalent conditions in predicting cardiovascular events in young to middle-aged adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Adipose tissue as an endocrine organ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Obesity : impact on cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Importance and management of dyslipidemia in the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The obesity paradox, weight loss, and coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Obesity paradox in patients with hypertension and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Body composition and prognosis in chronic systolic heart failure: the obesity paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The Obesity Paradox in Patients With Peripheral Arterial Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Disparate Effects of Left Ventricular Geometry and Obesity on Mortality in Patients With Preserved Left Ventricular Ejection Fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Body mass, fitness and survival in veteran patients: another obesity paradox?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Effect of Obesity on Short- and Long-term Mortality Postcoronary Revascularization: A Meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Overweight and obese cardiac patients have better prognosis despite reporting worse perceived health and more conventional risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Body composition and fitness in the obesity paradox--body mass index alone does not tell the whole story.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The interaction of exercise ability and body mass index upon long-term outcomes among patients undergoing stress-rest perfusion single-photon emission computed tomography imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Does fitness completely explain the obesity paradox?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Adiposopathy is "sick fat" a cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Effects of muscular strength on cardiovascular risk factors and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

A prospective study of muscular strength and all-cause mortality in men with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Adiposity and cardiovascular disease: are we using the right definition of obesity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The obesity paradox, cardiorespiratory fitness, and coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Value of weight reduction in patients with cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Body composition and coronary heart disease mortality--an obesity or a lean paradox?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Cardiovascular fitness and mortality after contemporary cardiac rehabilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Exercise-based cardiac rehabilitation and improvements in cardiorespiratory fitness: implications regarding patient benefit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Potential benefits of weight loss in coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

The role of exercise and physical activity in weight loss and maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

Physical activity promotion in the health care system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.010

10.1016/J.TRSL.2014.03.010

7 January 2021

Identifiers

DOI

1 reference

release_vvhhhl6nobg4ndqcvdto5iyrzy

31 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vvhhhl6nobg4ndqcvdto5iyrzy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

24726461

1 reference

PubMed ID

24726461